John Ryan

John Ryan

DirectoratUnicycive Therapeutics· In the 2023 proxy

John Ryan sits on 1 public board.

Experience

  1. Unicycive TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -44%
  2. Globavir Biosciences, Inc.Public company · 12 yr
    • Director2014 – Present · 12 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?